EMA: Updated Day 215 PI Annex Submission Checklist for Post-Opinion Linguistic Review
Update internal labeling workflows to align with the revised checklist; ensure submission documents meet updated formatting requirements for linguistic review.
Category
Regulatory intelligence from FDA, EMA, MHRA, and global agencies — guidance changes, committee outcomes, and pharmacovigilance policy updates.
Update internal labeling workflows to align with the revised checklist; ensure submission documents meet updated formatting requirements for linguistic review.
Stakeholders, including those involved in labeling and signal management, should consider the published comments to align future processes with the regulatory expectations detailed in the draft ICH E22 guideline.
MAHs should review the updated DRGD to understand new processing timelines for variation submissions and assess how the reliance mechanism can be leveraged for faster safety updates. Adjust internal timelines and processes for post-marketing variation submissions accordingly.
Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.
Digest roles: Labeling Lead. Work email only